Latest Blogs

Kaushal Pathak's picture

Challenges of Telemedicine Part 2

Submitted by Kaushal Pathak on Tue, 10/13/2009 - 04:25
3.75
Your rating: None Average: 3.8 (4 votes)

• Literacy rate and diversity in languages: Only 65.38 % of India’s population is literate with only 2% well-versed in English. So the rest of the people are facing a problem in adopting E-Medicine. Also, the presence of a large number of regional languages makes the applicability of single software difficult for the entire country.

Dr.S.Gunasakaran's picture

FDA Product Recalls - From First Alert to Effectiveness Checks

Submitted by Dr.S.Gunasakaran on Mon, 10/12/2009 - 09:40
4.333335
Your rating: None Average: 4.3 (3 votes)

Once a product is in widespread use, unforeseen problems can sometimes lead to a recall.

Dixon Thomas's picture

PHARMACIST- A HEALTH RELATED EMOTIONAL INTELLIGENCE MANAGER

Submitted by Dixon Thomas on Sun, 10/11/2009 - 16:04
4
Your rating: None Average: 4 (8 votes)

Emotion is the personal power, I dedicate this blog to all those who are strong users of emotion.

SUPRIYA VAVILAPALLI's picture

KRIMSON 35-THE DRUG MOSTLY USED TO TREAT PCOD

Submitted by SUPRIYA VAVILAPALLI on Sun, 10/11/2009 - 11:31
4.666665
Your rating: None Average: 4.7 (3 votes)

CYPROTERONE ACETATE AND ETHINYLOESTRDIOL TABLETS:

compositon:
Each film coated tablet contains:
cyproterone acetate BP 2mg
ethinyloestradiol IP 0.035mg

CLINICAL PHARMACOLOGY:
it combines with cyproterone acetate ,a potent antiandrogen and ethinyl oestradiol,a semisynthetic derivetive of oestradiol.

MECHANISM OF ACTION;

Shiv Majumdar's picture

Festive Season

Submitted by Shiv Majumdar on Sun, 10/11/2009 - 04:39
4.88889
Your rating: None Average: 4.9 (9 votes)

As we all know, DIWALI is nearby....

Through this blog our me and my team members are wishing all the readers of Pharmainfo.net a very HAPPY DIWALI...!

Shubham Karoti Kalyanam,

Arogram Dhana Sampada,

Shatru Buddhi Vinashay, Deepamjyoti Namostute...!

Shiv Majumdar's picture

Transdermal Delivery: Novel Approach: Case Study: Vyteris’ APS

Submitted by Shiv Majumdar on Sun, 10/11/2009 - 03:54
4.5
Your rating: None Average: 4.5 (6 votes)

Iontophoresis describes the technique whereby electrically charged molecules are moved across the skin by repulsive electromotive force. Vyteris has demonstrated successful delivery of peptides up to 3.5kDa

Shiv Majumdar's picture

Transdermal Delivery: Novel Approach: Case Study: Altea's PassPort

Submitted by Shiv Majumdar on Sun, 10/11/2009 - 03:52
4.5
Your rating: None Average: 4.5 (4 votes)

Altea Therapeutics is developing a transdermal patch with applications in delivering insulin, fentanyl citrate and a range of vaccines

Himanshu saurabh's picture

Challenges of Telemedicine Part 1

Submitted by Himanshu saurabh on Sat, 10/10/2009 - 17:08
4.666665
Your rating: None Average: 4.7 (3 votes)

Grudges and Hindrances:

Shiv Majumdar's picture

Transdermal Delivery: Novel Approaches

Submitted by Shiv Majumdar on Sat, 10/10/2009 - 05:31
4.666665
Your rating: None Average: 4.7 (3 votes)

A range of techniques has evolved aimed at increasing the skin’s permeability without irreversibly
changing barrier function

Chemical penetration enhancers:
Surfactants – fatty acids, fatty esters alter the structure of the stratum corneum. But they are not selective for intercellular lipids and also affect membrane lipids of epidermal cells and induce irritation

Sirisha Pingali's picture

Influenza A (H1N1) 2009 Monovalent Vaccine

Submitted by Sirisha Pingali on Fri, 10/09/2009 - 15:10
4.666665
Your rating: None Average: 4.7 (3 votes)

Influenza A (H1N1) 2009 Monovalent Vaccine is developed by Novartis Vaccines and Diagnostics Ltd. Given as suspension for Intramuscular Injection

INDICATIONS AND USAGE
• Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 4 years of age and older against influenza disease caused by pandemic (H1N1) 2009 virus